Paxlovid didn’t shorten Covid signs in vaccinated adults, complete trial effects ascertain
“If it’s Covid, Paxlovid.” That’s how Pfizer markets its Covid-19 antiviral, at the same time as the entire results of a find out about published within the New England Journal of Medicine